these were all nondiabetic patients who had been transplanted between 1979 and 1987 and received either azathioprine-methylprednisolone ( group 1 ) or cyclosporine-methylprednisolone ( group 2 ) therapy as maintenance immunosuppression .
C0025815
methylprednisolone
C0338242
cyclosporine-methylprednisolone